HAE.US Haemonetics Corporation

Healthcare Health Care Equipment & Supplies USA Stocks
122.94 USD
Close of Nov 15, 2026
51.00 132.00
Market cap
USD 5.60B
P/E
54.4x
P/B
6.23x
ROE
17.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is HAE.US undervalued?

Graham number

The Graham number of Haemonetics Corporation cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Haemonetics Corporation fundamental analysis

No fundamental analysis for Haemonetics Corporation yet.

Haemonetics Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Haemonetics Corporation

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmapheresis equipment system and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their dono…

Full company profile